Allergan To Close Five Manufacturing Plants By 2001 As Part Of Restructuring
This article was originally published in The Gray Sheet
Allergan will close half of its 10 global manufacturing facilities over the next three years as part of a corporate reorganization announced Sept. 15.
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.